ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Join SI Premium – FREE
ATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of ($0.91), $0.02 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $3.87 million versus the consensus estimate of $3.84 million.
For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Beam Global (BEEM) Tops Q2 EPS by 8c
- Jaguar Health (JAGX) Tops Q2 EPS by 3647c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
